• Novo Nordisk average return on investment for 2023 was 66.3, a 16.52% decline from 2022.
• Novo Nordisk average return on investment for 2022 was 56.9, a 14.09% increase from 2021.
• Novo Nordisk average return on investment for 2021 was 66.23, a 4.18% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.